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ABSTRACT

Platelet-Derived Growth Factor (PDGF) is a dimeric protein which exists in
PDGF-AA, PDGF-AB, and PDGF-BB isoforms.
major role

in

wound healing

vascular cells.

PDGF has been shown to play a

and the migration

and the proliferation

The PDGF isoforms interact with a dimeric PDGF receptor, aa,

ap, or pp, which exhibit isoform binding specificities.
proliferative
endothelial

of

and

migratory

cells

(BAECs),

influences

We identified the

of the PDGF isoforms

rat epididymal

fat pad capillary

on

bovine

aortic

endothelial cells

(RFCs), and bovine aortic smooth muscle cells (BASMCs).
In cells grown on Type I collagen (2D culture), treatment of BAECs with
the isoforms of PDGF did not affect migration or proliferation.

Treatment of

RFCs and BASMCs with PDGF-AB (10 ng/ml) resulted in 27% and 13% increases
in proliferation (p=0.006, p=0.048).
11% increase in migration (p=0.035).

BASMCs given PDGF-AB (10 ng/ml) had an
RFCs and BASMCs treated with PDGF-BB

(10 ng/ml) had a 100% and 50% increases in proliferation (p<0.001, p=0.002).
There was a 22% increase in migration of the BASMCs treated with PDGF-BB
(p<0.001).
In cells grown in a Type I collagen gel (3D culture), treatment of
BAECs and RFCs with the PDGF isoforms did not result in a change in
proliferation.

Conversely, proliferation increased

13%

in BASMCs given PDGF-

AA, 23% in cells given PDGF-AB, and 42% in BASMCs treated with PDGF-BB.
We conclude that the PDGF isoforms have similar effects in RFCs and
BASMCs in 2D culture in that PDGF-AB and PDGF-BB are promoters of five day
proliferation

which may be regulated through the

p

subunit of PDGF receptors.

Conversely, the PDGF isoforms do not affect the behavior of BAECs.

In addition,

RFCs grown in 3D culture do not respond to PDGF treatment while BASMCs do,
suggesting that RFCs are a cell population capable of modulating their

phenotype

in

extracellular

response
matrix.

to

changes

in

the

organization

of the

surrounding

INTRODUCTION

Platelet-Derived _ Growth

Factor

Platelet-Derived Growth Factor (PDGF) is a 30-34k mw heat stable,
basic,

dimeric protein

bonds.

whose two

polypeptide chains

are

linked

by

disulfide

The two chains, A chain and B chain (both 17k mw), are coded for

by different genes located on chromosomes 7 and 22, respectively but share
60%

amino

acid homology

including

eight

cysteine

residues

(1-4).

Waterfield, et al. and Doolittle, et al. have demonstrated that the B chain is
the

cellular

sarcoma virus
any

(c-sis)

proto-oncogene

(\-sis) (5,6).

protein

homologous

to

transforming

simian

The A and the B chains can associate in

dimeric combination giving rise to three possible PDGF isoforms:

PDGF-AA, PDGF-AB, and PDGF-BB.
Even before the

identification of the individual

isoforms it was

found that PDGF is differentially secreted by a variety of cells including
platelets,

macrophages,

fibroblasts,

and

carcinomas,
lung

vascular

neoplastic

colonic

carcinomas,

endothelial

cells

including

adenocarcinomas,

melanomas,

and

smooth

malignant

adrenal

fibrosarcomas,

muscle

gliomas,

carcinomas,

and

cells,
mammary

non-small

osteosarcomas

cell

(7-16).

PDGF is a potent mitogen for mesenchymal cells and has therefore been
associated
affect

with many

migration

healing,

induction

differentiation

of

and

actions

in different cell types including

proliferation

of cytoskeletal
progenitor

cells

of vascular
changes,
along

cells,

and the
specific

promote
ability

paths

to

the

ability

wound
affect the

during

normal

development.
Through some of the above mechanisms, PDGF has been linked
extensively

to

atherogenesis

and ischemia.

Specifically,

Bell

and

Madri

to

2

found that PDGF increases both the migration

and proliferation

of bovine

aortic smooth muscle cells but PDGF inhibited both proliferation
migration

in

neointimal

bovine

aortic

development

endothelial

by

smooth

cells,

muscle

suggesting
migration

a

role

and

and

for

subsequent

atheroma formation which may also serve as a nidus of platelet
aggregation (17).
mitogen

Furthermore, not only has PDGF been shown to be a

for vascular smooth

muscle cells

in vitro

(and

therefore

the benefit of a non-thrombogenic surface) but Golden, et al.
demonstrated

that

vascular smooth

muscle cells

PDGF even under an intact endothelium (18).

are

capable

who have demonstrated

with

actin

reorganization)

Evidence for the cytoskeletal

membrane ruffling (also
in

human

have

of secreting

manifestations of PDGF treatment on migration comes from
al.

without

foreskin

shown

Fibroblasts.

Mallestrom, et
to be

This

associated

was

felt

to

be a reaction specific for PDGF in that it was reversible with anti-PDGF
antibodies (19).

In addition to PDGFs effect on migration and proliferation

and their role in vascular pathology, PDGF has been shown to be a potent
vasoconstrictor causing

contraction

when

added

to

fresh

isolates

of rat

aorta (PDGF is more potent than Angiotensin II in this model), thus adding
the possibility

of increased

atherosclerosis

with

their

vascular tone
resulting

and

contribution

vasospasm
to

to

ischemia

underlying
(20).

With regard to the beneficial effects of PDGF, Greenhalgh, et al.
demonstrated that PDGF improved

wound healing in diabetic mice who

received

wounds

large

full-thickness

skin

compared

similar wounds but were not treated with PDGF.
considered to be improved

to

those

wound closure see at 21 days (21).

10 and 21

received

Wound healing was

given that there was an increased

fibroblasts and capillaries seen at

who

number of

days after injury and improved

PDGF is also implicated in normal

3

developmental pathways.

Noble, et al. and Richardson, et al. have

elucidated the role that PDGF plays in differentiation of bipotential
oligodentrocyte/type-2
type-1

astrocyte

progenitor

cells

(22,23).

In

this

system,

astrocytes secrete growth factors (largely PDGF) which act on the

bipotential

progenitor

oligodendrocytes

cells

(which

causing

will

them

myelinate

to

differentiate

neurons

in

the

into
central

nervous

system) or into type-2 astrocytes (which are associated with nodes of
Ranvier).

In addition, it has been demonstrated that PDGF promoted

progenitor

cell

progenitor

cells

motility
into

and

inhibits

the

premature

differentiation

of

oligodendrocytes.

The identification of the PDGF isoforms has led to the finding that
the secretion of individual isoforms is specific for a given cell type.

For

instance, 80% and 90% of mammary carcinoma cell lines tested by Peres, et
al. produced both PDGF-A chain and PDGF-B chain respectively (11) but
many other cells secrete only one type of chain.

Vascular smooth muscle

cells have been shown to secrete only PDGF-A chain whether the adjacent
intima was intact or had been subjected to denudation injury (18,24).
Fingerle, et al. showed an increased secretion of only the A chain after
denudation.

Some

vascular

endothelial

cells,

conversely,

amounts of B chain but very little A chain (25,26).

produce

large

Mendoza, et al. have

demonstrated the increased production of PDGF-A chain mRNA (but not B
chain

mRNA) by

smooth muscle cells

in the gravid versus non-gravid

uterus and have proposed that PDGF-A chain is intimately linked with
uterine expansion during pregnancy
human

embryonal
PDGF-B

cell

carcinomas

(27).
secrete

O'Donnell, et al.
PDGF-A

chain

found that

(13).

chain has been localized in macrophages during all stages

of atherogenesis (8) and the homodimer of PDGF-B chain (PDGF-BB)

■

I

4

improved healing of full

thickness skin wounds in

diabetic mice (21),

Beckmann, et al. suggest that the PDGF-B chain has a greater ability to
transform

cells

than PDGF-A chain

which

is consistent

that the PDGF-B chain is homologous to the c-sis

with the finding

proto-oncogene (28).

Some investigators have suggested that the actions of PDGF-BB and the PDGF
heterodimer,

PDGF-AB,

are

similar, differing only

with

respect to

intensity

of response, whereas the actions of PDGF-AA are often disparate from those
of the PDGF isoforms which contain a B chain.

Siegbahn, et al.

demonstrated that PDGF-AB and PDGF-BB have chemotactic effects on
monocytes and fibroblasts whereas PDGF-AA does not (29).

Similarly,

Hammacher, et al. have demonstrated that only PDGF-AB and PDGF-BB are
capable

of

causing

the

membrane

ruffling

in human foreskin fibroblasts (30).

and

actin

reorganization

seen

The PDGF receptor has been implicated

in generating this vast number of actions that PDGF has on effector cells.

Platelet-Derived

Growth

Factor

Receptor

The PDGF receptor is composed of a dimer of two 170-180 kDa
transmembrane
this

activity

proteins

as its

in

five

kinase

family

contain

intracellular split
possesses

which

uses

The receptor is a

The receptor subunits share 44% homology, both

immunoglobulin-like

subunit

tyrosine

subunits and associate as either homo- or

act, ap, pp.

contain

receptor

split

intracellular signalling mechanism.

dimer consisting of a or p
heterodimers:

the

tyrosine
a

domains
kinase

specific

extracellularly,

domains

(31,32).

PDGF chain

dimers differentially bind the PDGF isoforms (Figure

and

Because

preference,
1).

both

the

each

receptor

Specifically, the a

receptor subunit will bind either PDGF-A chain or PDGF-B chain whereas
the P receptor subunit will only bind the PDGF-B chain.

Based on these

5

specificities, a (3(3 receptor will bind PDGF-BB with the greatest affinity,
PDGF-AB to a slight degree, and PDGF-AA not at all.

An aa PDGF receptor,

conversely, will bind all three isoforms of PDGF (33,34).
Once the PDGF molecule is bound to the receptor, there is
internalization of the

receptor-ligand complex

phosphorylation-mediated

conformational

resulting

change

in

in

the

a

PDGF

receptor

(which only takes place in the presence of ATP) which induces the
tyrosine kinase activity (35,36).
intrinsic

tyrosine

kinase

Sorkin, et al. demonstrated that while the

enhances

not an essential for this action (35).
kinase

activity

reorganization,

was necessary
and migration.

receptor-ligand

internalization,

it

was

Westermark, et al. found that tyrosine

for membrane
Porcine

aortic

ruffling,

cytoskeletal

endothelial

cells transfected

with tyrosine kinase negative P(3 receptors did not exhibit these actions
while those with the wild-type PP receptor did (36).

While the exact

sequence of events remains elusive, it is generally held that ligand binding
stimulates

the

breakdown

of phosphotidyl

inositol

bisphosphate

followed

by the generation of inositol trisphosphate and diacylglycerol as second
messengers.

Inositol

trisphosphate

promotes

the

release

of intracellular

calcium stores while diacylglycerol leads to the activation of protein kinase
C (37,38).

Sachinidis, et al., found a detectable increase in diacylglycerol

within 20 seconds after the addition of recombinant PDGF-AB or PDGF-BB to
rat aortic smooth muscle cells.

In these cells, PDGF-AA had a slower and

highly variable ability to stimulate diacylglycerol production.

This

production peaked at one minute with a six-fold increase in diacylglycerol
and a fall off to its stable and half-maximal concentration six minutes after
stimulation.

Reasonably low doses of PDGF-AB or PDGF-BB (1-30 ng/ml)

caused a seven to twelve-fold increase in inositol trisphosphate production

6

in rat aortic smooth muscle cells while PDGF-AA had no effect on inositol
trisphosphate

production

in

these

cells

(39).

Given that there are only three PDGF receptor configurations and

a

multitude of cell responses to PDGF, Gronwald, et al. have postulated that the
multitudinous effects of PDGF are a reflection of differing absolute and
relative numbers of receptor types expressed on cells (40).
identified the a

receptor

subunit

which

possesses

tyrosine

in the cDNA library of rat olfactory epithelium (41).
evidence that both a and p

kinase

activity

Werner, et al. have

receptor subunits exist on the surface of

cultured Kaposi sarcoma cells (42).
not P

Lee, et al. have

Hermansson, et al. have identified a but

receptor subunits in human glioma cells, whereas Wang, et al. have

identified

functional

PDGF

receptors

human meningioma cells (9,43).
receptor subunits

in

an

anaplastic

containing

the

p

subunit in cultured

Similarly, Heldin, et al. demonstrated p
thyroid carcinoma

(10).

Given that

PDGF-AB and PDGF-BB were the only isoforms to cause membrane ruffling
and

actin

reorganization,

with the P

al.

deduced

that PDGF interaction

receptor subunit was essential for this action (30).

Yablonka-Reuveni,
from

Hammacher, et

et al.

demonstrated

adult skeletal muscle) express pp

that

mouse

receptors.

C-2

Recently,

myoblasts

(derived

When stimulated with the

different isoforms of PDGF, PDGF-BB causes a five-fold increase in cell
proliferation

with

a

decrease

in

differentiation

(as

measured

by

the

amount of myosin in cells) compared to the cells treated with PDGF-AA and
PDGF-AB (44).
different cell

Expanding on Gronwald's idea that the actions of PDGF in

types

are

a reflection of the

in receptor expression, the addition of

absolute

and

relative

differences

independent regulation of A and B

chains can explain the multitudinous effects of PDGF.

7

PDGF and PDGF Receptor Interaction
Mercola, et al. illustrated that both the A and B chains of PDGF and
the a and p

receptor subunits

under independent control
A chain

was

expressed

are expressed differentially

(45).

and may

be

These investigators found that only PDGF-

in mouse embryonic

6.5 to 8.5 days and that while both a and p

and extraembryonic

receptor subunits

tissue at

are expressed

in the mouse embryo, the a subunit is expressed both earlier and to a
greater degree than the P

subunit.

Several neoplastic cell

lines have been

shown to contain both PDGF receptors and the ability to secrete PDGF.
Hermansson, et al. and Nister, et al. illustrated this point in malignant
glioma cell lines suggesting the possibility of an autocrine loop as a
mechanism

for neoplastic

growth (9,46).

embryogenesis and neoplasia, however.
phase

process

in

arterial

rat carotid arteries (47).

repair

This interaction is not confined to
Majesky, et al. proposed a two

after balloon

catheter denudation

injury

to

In the acute phase (first six hours) they observed

a significant decrease in the amount of P

subunit expressed

on

smooth

muscle cells while seeing a 10-12-fold increase in the amount of PDGF-AA
expressed and no change in either PDGF-B chain or a
In

the chronic

phase of repair (two weeks after injury) the

cells expressed a smaller amount of a

expression

of PDGF

expression.

smooth

muscle

subunit mRNA but an increased

amount of p subunit mRNA expression.
differential

subunit

In addition there may be

receptor

subunits

PDGF chains in the same cell type in this model.

and

secretion

of specific

Specifically, the smooth

muscle cells which were located on the luminal side, i.e., close to the site of
the denudation injury, expressed a larger amount of PDGF-A chain and P
receptor

subunit than

smooth

site of intimal damage.

muscle

cells

located

farther

away

from

the

8

Expression of PDGF receptor subunits may also be affected by other
growth factors.

Gronwald, et al.

"transmodulation"

in

which

describe a phenomenon they term

Transforming

Growth

Factor-p

regulates the expression of PDGF receptor subunits (48).
investigators found that quiescent 3T3

(TGF-P)
These

cells which were treated with 24

hours of TGF-P bound almost no PDGF-AA and PDGF-AB, but had only a 40%
reduction in their ability to bind PDGF-BB compared to controls.
expected, these cells also expressed a diminished number of a
subunits while the number of P

receptor

subunits

was

As
receptor

increased.

B&&fcai£fe_Ons-siims
Investigators have

identified the structure of PDGF and

in many different cell types.
function,

however,

receptor binding

was

function

Much of the work elucidating PDGF's

performed

specificities

its

were

before

the

specific

recognized.

In

isoforms

addition,

and

while

the
the

mitogenic effect of PDGF on vascular smooth muscle cells is well
characterized, the effect of PDGF on vascular endothelial cells is still under
investigation.

Bar, et al. found that PDGF did not affect ^H-thymidine

incorporation

(a

measure
and
small

measure

of proliferation)

pulmonary
vessel

artery),

endothelial

of DNA

synthesis

in

vessel

large

whereas
cells

there

therefore

endothelial

was

(bovine fat

and

increased

and

an

cells

indirect

(bovine

aorta

^H-thymidine

mouse brain

in

capillaries)

(49).

Conversely, Bell and Madri did identify an effect in large vessel endothelial
cells.

Specifically, these authors found that PDGF decreased the migration

and proliferation of bovine aortic endothelial cells (17).
studies,
isoforms

however,
and

the

Both of these

were performed before the isolation of the different PDGF
advent of recombinant technology.

In

the present

study,

9

I

will

use

determine
endothelial

functional

assays

whether the
cells

and

which

specific
vascular

types

of endothelial cells

react

differently to

measure

migration

PDGF

isoforms

smooth

muscle

(namely

small

and

have
cells

large

and

proliferation

differing
and

actions

whether

vessel

to

on

different

endothelial

cells)

PDGF treatment.

Secondly, Madri, et al. have demonstrated some cell populations can
modulate
are

their

cultured.

influence

cell

phenotype

Environmental
morphology

soluble

factors,

(versus

the traditional

the

phenotypic

grown

in

two

depending

and

on

changes
include

culturing

cells

which

in

and

have

three

been

in

which

shown

matrix

they

to

components,

a three-dimensional

collagen

gel

culture

seek to

compare

of endothelial

dimensional

environment

extracellular

two-dimensional

responses

the

and

system).

I

vascular smooth

dimensional

cultures.

muscle

(50)

cells

10

METHODS

Cells and Culture
Microvascular endothelial

cells

were

cultured

by

Ms.

Adeline

Tucker from the fat pad capillaries of rat epididymides (RFCs) as described
by Madri and Williams (51).
Sprague-Dawley

rats

were

Briefly, the epididymal fat pad of 400 g
removed

from

recently

sacrificed

animal

and

placed in sterile Williams HEPES buffer (NaCl 140mM, HEPES lOmM, KC1
lOmM, CaCl2 O.lmM, MgCl2 0.2mM, NaHC03 11.9 g/1, glucose 5.0 g/1, pH 7.4).
Pieces of fat which appeared to be free of large blood vessels were minced
and placed in a solution of HEPES buffer and collagenase (Type II 250 mg/50
ml HEPES buffer, Sigma).

After incubation at 37° with agitation (for

approximately one hour), the suspension
seven minutes.

was centrifuged

at 200

g for

The pellet was washed in HEPES buffer and 5% bovine

serum albumin twice and then centrifuged at 200 g for five minutes.
pellet

was

then

resuspended

and recentrifuged

at

in

15,000 g

45%

for 20 minutes

capillary tufts in the tissue isolate.
bovine

serum

Percoll

(Pharmacia Fine
resulting

Chemicals)

identifiable

The tufts were then washed with HEPES-

albumin buffer and then plated on

previously coated with

in

The

60-mm

Petri

dishes

12.5 mg/ml Type I and Type III collagen in medium

(199 E, Gibco) with 20% fetal bovine serum, penicillin, streptomycin, and
glutamine.
serum

To this medium was added an equal amount of 10% fetal bovine

medium

conditioned

by

confluent

bovine

aortic

endothelial

cells.

This medium was used to maintain the RFC population (RFC medium).
cells were maintained in an incubator containing 5% CO2,
atmostphere at 37°C.

95%

The

humidified

The cells were passaged to

1:3 split ratio when confluent

(approximately every seven days) in 0.2% trypsin with EDTA.

The

endothelial cell origin of these cells was confirmed by the presence of
angiotensin-converting

enzyme

activity

VIII (data not shown, see ref 51).

and

reactivity

with

anti-factor

Passages four through ten were used for

experiments.
The large vessel endothelial
intima and media,

used

in

the

cells, i.e., vessels which contain both

following experiments were bovine

aortic

endothelial cells (BAECs) and were isolated from calf aorta by Ms. Adeline
Tucker (52).
washed

in

The vessel was obtained from a slaughterhouse and was

iced

streptomycin,

phosphate buffered

saline

and fungisone added.

The

(PBS)
aortic

with

penicillin,

adventitia was dissected

from the vessel and both ends of the aorta were cannulated.
washed

with

a

PBS/penicillin/streptomycin

solution of 20%
added.
filled

and

199E medium (Gibco) with penicillin

then

with

a

and streptomycin

The distal end of the aorta was then clamped and the lumen was
199E medium

incubated

for

The
then

solution

The intima was

with

1

mg/ml

(Worthington)

and was

minutes.

media/collagenase

washed

containing

30

with collagenase

20%

glutamine,

solution

was

heat-inactivated

penicillin,

and

removed

fetal

bovine

streptomycin.

and

the

serum
The

lumen

was

199E medium
aorta

was

then

massaged and the contents of the lumen were plated on a 75 cc tissue
culture flask and were incubated at 37°C with 5% CO2.
The cells were fed 10% fetal bovine serum medium (DM, Gibco)
supplemented

with

glutamine,

This medium containing

penicillin,

and

streptomycin

10% fetal bovine serum

twice

weekly.

was used to maintain the

BAEC and bovine aortic smooth muscle cell (BASMC) populations (10% FBS

12

medium).

The cells were passaged at a 1:3 split ratio when confluent (about

every seven days) in 0.2% trypsin with EDTA.
these

cells

enzyme

was

activity

ref 51).

confirmed
and

by

reactivity

the
with

presence

The endothelial cell origin of
of

angiotensin-converting

anti-factor VIII

(data not

shown,

see

Passages four through ten were used for experiments.
Bovine aortic smooth muscle cells (BASMCs) were isolated by Ms.

Adeline Tucker from

fresh

calf aorta obtained

Using sterile conditions, each
intima.

a

slaughterhouse

(52).

aorta was cut lengthwise to expose the

The intimal surface was rubbed with sterile gauze to denude the

endothelium.
away

from

The most intimal layer of smooth muscle cells was teased

in strips from the remaining media using sterile forceps and was

then placed in a Petri dish.

These strips were then minced to a very fine

consistency and were then covered with a small amount of 10% FBS medium
so that the minced strips remain in contact with the Petri dish.

After

several days, the smooth muscle cells which were later used for culture
migrated away from the minced strips.
serum

medium

(DM,

Gibco)

streptomycin twice weekly.

The cells were fed

supplemented

with

glutamine,

10% fetal bovine
penicillin,

and

The cells were passaged at a 1:3 split ratio

when confluent (about every seven days) in 0.2% trypsin with EDTA.
Passages

two

Proliferation

through

of Cells

five

in

were

used

for experiments.

Two-Dimensional

Cultures

Petri dishes were coated with Type I collagen (12.5 pl/ml
in a sodium carbonate buffer at pH 9.3), stored overnight at 4°C,

dissolved
and washed

three times with warm PBS and 2 ml of medium was placed in each dish.
The cells, whether BAECs, RFCs, or BASMCs, were prepared by trypsinizing a
75 mm tissue culture flask and resuspending the cells in medium.

A
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suspension of 1.4 x 104 cells in 1.5 ml medium was added to each of the
dishes and the dishes were incubated for six hours at 4°C in a 5% CO2
incubator.

After six hours, the cells were treated with either RFC or 10%

FBS medium (depending on which cell type was used) containing no PDGF
(control

group) or medium containing a specific PDGF isoform

reincubated.
three days.

The cells

were

fed

medium

and were

containing their treatment at

After one, two, or five days the dishes were treated with 0.2%

trypsin to lift the cells from the dish and the absolute number of cells/ml
was determined using a Coulter Counter.

2-H

Thymidine

Incorporation

Quantitative
DNA

synthesis

Approximately

^H-thymidine uptake has been used as an

and

therefore

as

an

indirect measure

of cell

indication of
proliferation.

12,000 BASMCs were plated onto a 24-well bacteriologic

culture dish that had been coated with Type I collagen (12.5 pg/ml).

The

BASMCs were allowed to attach to the matrix for six hours and were then
treated with
ng/ml)

10% FBS medium containing a specific PDGF isoform (10

or without

any

or 48 hours at 37°C.

growth

factor (control)

and

were

incubated

for 24

In a radioactive hood, the cells were treated with a 1%

solution of ^H-thymidine in 10% FBS medium and were incubated at 37°C for
4 hours.

The cells were washed with PBS and were treated with a

methanol/acetic

acid solution (3:1) for ten minutes.

The cells were then

treated with a chilled 20% trichloroacetic acid solution (in ddH20) and were
then washed with PBS.
overnight.
(Packard)
using

The cells were left in a 0.2M NaOH solution at 37°C

The cell/NaOH solution was added to 3.5 ml of Optifluor solution
and placed in a scintillation vial.

a Bechman LS

The radioactivity was measured

300 scintillation counter.
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Proliferation

of Cells

Evaluation

in Three

of cell

Dirnensign$al_Q}lLLLrg^

proliferation

in

three

dimensions

was

performed

by suspending and culturing cells in a Type I collagen gel as described by
Madri, et al. (53).

To prepare the gel, lyophilized bovine calf dermis was

suspended in sterile
at 4°C overnight.

10 mM acetic acid (5 mg/ml) and was stirred overnight

A known amount of the Type I collagen solution was

placed in a cold, sterile 50 cc tube and ten percent of this volume of HESS
was added.
the

Approximately 50 pi of IN NaOH were added in 10 pi aliquots to

solution,

vortexing

after each

addition,

until

from yellow to pink which indicated a pH of 7.0.

the pH

indicator changed

BAECs, RFCs, or BASMCs

were added to the Type I collagen suspension until a concentration of 106
cells/ml

was

reached.

The cells were added to millicells (0.5 ml/millicell) placed in a 24well culture dish and were incubated at 37°C for several minutes until the
gel solidified.

RFC or 10% FBS medium (with or without PDGF) was added to

the 24-well culture dish and the gel was incubated at 37°C.

The cells were

fed with media with or without PDGF the following day and on day three.
After five days, the collagen gel was washed five times with PBS and
were digested in 3 ml of a collagenase solution consisting of PBS, type II
collagenase at 1 mg/ml (Sigma), CaCl2 ImM, and MgCl2 ImM.

The gels were

digested in this solution for approximately an hour in a 37°C

shaking

bath.

water

An equal volume of medium was added to the digested gel solution,

and an aliquot of this new solution was used for counting the cells in either
a Coulter Counter or using

a hemocytometer.
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Migration

Assay

Cell

migration

was determined using

described by Pratt, et al. (54).

a radial migration

assay

Prior to the migration assay, 35 mm

bacteriologic Petri dishes (Falcon) were coated with 2 ml of Type I collagen
(12.5 pl/ml) dissolved in a sodium carbonate buffer at pH 9.3.
were kept overnight at 4°C.

The dishes

The dishes were washed three times with warm

sterile PBS and 2 ml of 10% FBS medium was added to each dish.
Stainless steel fences (approximately 4 cm in diameter,

1

cm high,

with a 1 cm hole cut in the center; see ref 52) were added to each of the
Petri dishes and the media contained in the center well was removed.

A

BAEC or BASMC cell suspension which was made by trypsinizing a 75 mm
tissue culture flask and resuspending the lifted cells in

10% FBS medium

and 0.4 ml of this cell suspension was placed in the center well of each of
the fences.
hours

to

The dishes were incubated in a 37°C, 5% CO2 incubator for six
allow attachment

and confluence of the

suspended cells.

After six hours, the fences were removed thus releasing the cells
from contact inhibition and allowing the cells to migrate radially.

At the

time the fences were removed, the cells were washed with PBS to remove
any

nonadherent

experimental
with

cells

and

were

treatment being

Platelet-Derived

Growth

then

treated

investigated.
Factor

with

In the

(PDGF),

the

specific

case of cells

whether the

given

treated
treatment

was PDGF-AA, PDGF-AB, or PDGF-BB, 1.5 ml of medium containing 10 ng/ml
PDGF was added to each dish.
served as controls.

The cells treated with 10% FBS medium alone

New medium containing the same treatment was added

to each dish after three days.

After five days, the cells were fixed in 10% buffered formalin and
stained

with hematoxylin.

cells

were

traced

Data

Analysis

using

The

areas covered

MacMeasure

(Yale

by

the radially

migrating

Shareware).

Data were analyzed using CLINFO, an NIH-sponsored statistical
analysis program.
tailed).
analyzed
Test

to

groups.

Data were analyzed using Student's t-Test (unpaired, 2

For comparisons of more than two conditions, the data were
using
test

Analysis

for

of Variance

significant

with

differences

Newman-Keuls

between

individual

Multiple

Range

treatment

Data are expressed as mean +_ standard error and significance

defined as probability less than 0.05.

was
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RESULTS

Proliferation in Two Dimensional Cultures:

Dosage in RFCs

The dose response that each PDGF isoform had on proliferation was
measured in RFCs,

The effects were measured after five days based on cells

grown on collagen Type I in 0.5% fetal bovine serum medium and the doses
of each PDGF isoform used were 0.625 ng/ml, 1.25 ng/ml, 2.5 ng/ml, 5.0
ng/ml,

and

10.0 ng/ml

(Figure 2).

When the proliferation of RFCs was measured in cells receiving
different doses of PDGF-AA, there was no significant change in
proliferation compared to control treatment regardless of the dose of PDGFAA used (Figure 2).

Specifically, the change in proliferation ranged from a

9% decrease in those cells treated with PDGF-AA at 0.625 ng/ml to a decrease
in proliferation of 38% in those cells treated with PDGF-AA at 1.25 ng/ml.
There was no increase in proliferation in any of the groups treated with
PDGF-AA

and

all of the treatment groups were not significantly

from those cells treated with

different

10% fetal bovine serum alone.

Some of the doses of PDGF-AB were associated with an increase in
proliferation in RFCs as seen in Figure 2.
ng/ml

resulted

in

Treatment with PDGF-AB at 0.625

a 6% increase in proliferation (p=NS)

while cells treated

with PDGF-AB at 1.25 showed a 24% increase in proliferation (p=NS).

Cells

treated with PDGF-AB at a dose of 2.5 ng/ml had a 33% increase in
proliferation compared to control (p=0.010).

Those RFCs treated with PDGF-

AB at 5.0 ng/ml showed a 60% increase in proliferation compared to control
(p=0.001 vs control, p<0.05 vs 0.625 ng/ml, 1.25 ng/ml, and 2.5 ng/ml).

The

RFCs treated with PDGF-AB at 10.0 ng/ml demonstrated a 63% increase in
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proliferation compared to control cells (p=0.004, also p<0.05 vs 1.25 ng/ml,
2,5 ng/ml, 5.0 ng/ml).
RFCs treated with some doses of PDGF-BB also showed an increase in
proliferation compared to cells treated with 0.5% fetal bovine serum
medium alone at some doses (Figure 2).

Cells treated with 0.625 ng/ml

showed a 45% increase (p=NS) while RFCs treated with PDGF-BB at 1.25
ng/ml had a 79% increase in proliferation (p=0.027).

Cells treated with

PDGF-BB at 2.5 ng/ml demonstrated a 118% increase in proliferation
compared to control (p=0.Q01, p<0.05 compared to 0.625 ng/ml).

The group

treated with 5 ng/ml had a 163% increase in proliferation compared to the
cells treated with medium alone (p<0.001, and p<0.05 compared to 0.625
ng/ml and 1.25 ng/ml).

Finally, the RFCs that were treated with PDGF-BB at

a dose of 10.0 ng/ml had a 195% increase in proliferation compared to
control (p=0.002, p<0.05 compared to 5 ng/ml, 2.5 ng/ml, and 1.25 ng/ml).

Proliferation of Two Dimensional Cultures;_Dosage in BASMCs
The dose response of the PDGF isoforms were examined by Dr.
Martin Marx in BASMCs in 0% fetal bovine serum medium on Type I
collagen (Figure 3).

These cells were grown in two dimensions and

absolute cell number was measured after five days.

The doses of each

isoform used were 1.25 ng/ml, 2.5 ng/ml, 5/0 ng/ml, 10.0 ng/ml, and 20.0
ng/ml.
As in RFCs, treatment with PDGF-AA was not associated with
significant changes in proliferation of BASMCs regardless of the dose tested
as seen in Figure 3.

Specifically, the responses ranged from a 12% increase

in proliferation compared to control with PDGF-AA at 1.25 ng/ml to a 6%
decrease in proliferation with PDGF-AA at 20.0 ng/ml.
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When BASMCs were treated with PDGF-AB, some of the doses tested
were

associated

with

significantly

increased

proliferation

compared

cells treated with 0% fetal bovine serum medium alone (Figure 3).

to

PDGF-AB

at a dose of 1.25 ng/ml resulted in a 6% increase in proliferation (p=NS)
while cells treated with with 2.5 ng/ml had a 32% increase in proliferation
(p=0.016,
ng/ml had

p<0.05 vs 1.25 ng/ml).
a 43%

increase in proliferation compared to the control

(p=0.007, p<0.05 vs 1.25 ng/ml).
associated

with

Those BASMCs treated with PDGF-AB 5.0
group

Treatment with PDGF-AB atlO.O ng/ml was

a 60%increase in cell number compared to control cells

(p<0.001, p<0.05 compared tol.25 ng/ml and 2.5 ng/ml).
was somewhat diminished when PDGF-AB

This proliferation

20 ng/ml was the treatment, with

the BASMCs having a 56% increased proliferation over the control cells
(p-0.001, p<0.05 compared to 1.25 ng/ml and 2.5 ng/ml).
As in the RFCs, BASMCs which were treated with increasing doses of
PDGF-BB

demonstrated

increasing

degree

of proliferation

compared

to

BASMCs treated with 0% fetal bovine serum medium alone as illustrated in
Figure 3.

Those BASMCs given PDGF-BB 1.25 ng/ml had a 1.3% decrease in

proliferation compared to control

(p=NS) while giving PDGF-BB

2.5 ng/ml

to these cells was associated with a 12% increase in proliferation (p=NS).
The BASMCs treated with PDGF-BB at 5.0 ng/ml proliferated 26% more than
control cells (p=0.024), while cells which received PDGF-BB
a 56% increased proliferation (p=0.011, p<0.05 compared to
ng/ml, 5.0 ng/ml).
a

Those

10.0 ng/ml had
1.25 ng/ml, 2.5

BASMCs which received PDGF-BB 20.0 ng/ml had

129% increased proliferation compared to control cells (p<0.001, p<0.05

compared to

1.25 ng/ml, 2.5 ng/ml, 5.0 ng/ml,

10.0 ng/ml).

Based on the above data in both RFCs and BASMCs, the dosage used to
compare the differing effects of the PDGF isoforms was

10.0 ng/ml in that
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this dose fell well

above the dose needed to generate increased proliferation

in both RFCs and BASMCs for both PDGF-AB and PDGF-BB.

Proliferation of Cells in Two Dimens.i.ona.l-£ulture&:_Five Day Data (IQ
ng/m!)
The treatment of BAECs with PDGF-AA, -AB, and -BB at 10 ng/ml did
not

significantly

affect

cultures (13%, 9%,
Figure

five

and

23%

day

cell

proliferation

in

two

increase compared to control,

dimensional
respectively;

4).
When RFCs grown in two dimensional cultures were treated with

the PDGF isoforms at 10 ng/ml, each isoform had a different effect on cell
proliferation after Five days (Figure 5).

When treated with PDGF-AA, the

RFCs had only a 6% increase in proliferation compared to controls (those
treated with RFC medium with no added PDGF, p=NS), while those RFCs that
were treated with PDGF-AB had a 27% increase in proliferation (p=0.006,
p<0.05 compared to PDGF-AA group).
there was

100%

increase

When RFCs were treated with PDGF-BB,

in proliferation compared to controls

(p<0.001,

p<0,05 compared to PDGF-AA, and PDGF-AB groups).
When BASMCs grown in two dimensional culture were treated with
10 ng/ml PDGF isoforms in 10% FBS medium, those cells treated with PDGFAA showed a

1% decrease in proliferation compared to controls after five

days (p=NS; Figure 6).

The BASMCs treated with PDGF-AB showed a 13%

increase in proliferation (p=0.048), and those cells treated with PDGF-BB
showed a 50% increase in proliferation compared to control cells (p=0.002,
p<0.05 compared to PDGF-AA, PDGF-AB).
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Early Proliferation of BASMCs in Two Dimensional Culture;_Cdi„Nmb-£I
In order to determine whether the PDGF isoforms exhibit their
actions at different points in time, the 24 and 48 hour proliferation was
measured by counting the number of BASMCs grown in two dimensional
culture

(Figure

7).

After 24 hours, those BASMCs treated with PDGF-AA (10 ng/ml)
showed a 14% increase in cell number (p=NS).

Those cells given PDGF-AB

had a 24% increase in cell number (p=0.012), and those BASMCs treated with
PDGF-BB demonstrated a 54% increase in cell number (p=0.0Q7).
After 48 hours, the BASMCs treatment with PDGF-AA was associated
with a 29% increase in cell number (p=0.003), while treatment with PDGFAB resulted in a 15% increase in the number of cells (p=0.028).

Treatment

of BASMCs with PDGF-BB was associated with a 65% increase in cell number
at this point in time (p<0.001).

Early Proliferation of BASMCs in Two Dimensional Culture:

2-H-Thymidine

Incorporation
DNA synthesis in BASMCs grown in two dimensional cultures
measured

by

^H-thymidine

incorporation

indirect measure of cell proliferation.
thymidine

incorporation

proliferation

as

has

traditionally

been

used

In the present study, the

-

after PDGF treatment

measured

by

cell

counts

was

(Figure

compared

to

as

an

changes

in

8).

After 24 hour treatment with specific PDGF isoforms (10 ng/ml in
10% FBS medium), those BASMCs treated with PDGF-AA expressed a 28%
increase in

scintillation counts compared to

control

(p=0.004)

(Figure

7).

Those cells treated with PDGF-AB showed a 19% increase (p=0.014), and
those cells treated with PDGF-BB had a 4% decrease in scintillation counts

22

(p=NS).

After treatment for 48 hours, the BASMCs which received PDGF-AA

showed a 91% increase in radioactivity (pcO.OOl) (Figure 8), while those
treated with PDGF-AB had a 31% increase (p=0.023).

Those BASMCs

receiving PDGF-BB for 48 hours had a 53% increase in radioactivity
compared to control

Proliferation

(p=0.001).

of Cells in.Three

Dimensional

Cultures

When the five day proliferative effects of PDGF-AA, -AB, and -BB (10
ng/ml) were measured in BAECs grown in a Type I collagen gel, there was
no
(5%

significant

difference

increase, 4%

between

decrease,

the treated

and 6%

increase,

cells

and

the

respectively)

control

cells

(Figure 9).

Similarly, Dr. Martin Marx found that the proliferation of RFCs grown in
three dimensional culture and treated with PDGF-AA, -AB, -BB (10 ng/ml)
did not differ significantly from control (1%, 6%, and 7% decrease
respectively)

(Figure

10).

When the effects of the different PDGF isoforms were measured in
BASMCs, there was a strong trend toward significance which could not be
analyzed

statistically because of small sample sizes (Figure

11).

Specifically, those BASMCs treated with PDGF-AA (10 ng/ml) had a 13%
increase

in

cell

number after four days,

while those

with PDGF-AB had a 23% increase in cell number.
received PDGF-BB

which

were treated

Those BASMCs which

demonstrated a 42% increase in cell number.

Migration
PDGF did not affect the degree of radial migration in BAECs grown
on Type I collagen (Figure 12).

Specifically, treatment with PDGF-AA, -AB,
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and -BB (10 ng/ml) had a 0.3%, 1%, and 2.8% increase in migration,
respectively.

These

differences

were

not

statistically

significant.

BASMCs grown in 10% FBS medium had different reactions to
treatment with the different isoforms of PDGF (Figure 13).

The BASMCs that

were treated with PDGF-A A at 10 ng/ml demonstrated a 1% increase in
migration compared to those cells grown in 10% FBS medium alone (p=NS).
The cells treated with PDGF-AB showed an

11% increase in migration

compared to control (p=0.035 , p<0.05 compared to PDGF-AA), and those
BASMCs treated with PDGF-BB had a 22% increase in migration compared to
control (p<0.001, p<0.05 compared to PDGF-AA, and PDGF-AB).
Previous
migrate

under

experiements have demonstrated that RFCs

these

conditions

(data

not

shown).

will

not
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DISCUSSION

The Effect of PDGF Isoforms
Platelet-derived Growth Factor (PDGF) is a ubiquitous dimeric
protein

whose

actions play

and both vascular injury

a major role

and repair.

in normal

In an

development,

neoplasia

attempt to further clarify the

interaction between PDGF and vascular cells, large

and small vessel

endothelial cells

were treated

and vascular smooth muscle cells

with

the

three isoforms of PDGF and proliferation and migration of these cells were
measured.

Previous work by Bell and Madri in bovine aortic smooth muscle

cells (BASMCs) and bovine aortic endothelial cells (BAECs) treated with
Mitomycin C illustrated that these two processes

are independent

(17).

After five days of treatment with PDGF, a consistent relationship
emerged

with

respect

to

the

two

dimensional

proliferative

and

migratory

responses of rat epididymal fat pad capillary endothelial cells (RFCs) and
BASMCs to the specific isoforms of PDGF.

Namely, when proliferation (i.e.,

absolute number of cells) was measured in RFCs and BASMCs treated with
the different isoforms of PDGF grown in two dimensions, PDGF-AA did not
induce a significant change compared to control cells.

PDGF-AB was

associated with a significant increase in proliferation in RFCs and BASMCs
while the cells treated

with PDGF-BB

demonstrated

over control or cells treated with PDGF-AB.
for the radial migration of BASMCs.

a significant

increase

The same relationship held true

Specifically, the migration of those

cells treated with PDGF-AA did not differ from control while those given
PDGF-AB or PDGF-BB did.

In addition, the cells treated with PDGF-BB

migrated

than those

significantly

more

cells

given PDGF-AB.
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The relationship identified between the three isoforms of PDGF and
increasing

proliferation

other investigations.
varied somewhat.

and

migration

is

consistent

with

that

identified

by

The doses of PDGF used in these studies, however,
In general, the PDGF doses examined in the present study

are within the range examined in other investigations.

Siegbahn, et al.

found that PDGF-AB and PDGF-BB were chemotactic for both monocytes and
fibroblasts, but that PDGF-AA had no such effect (29).

Sachinidis, et al.

found that treatment with recombinant PDGF-AB and PDGF-BB (at doses
between 3 and
incorporation,
calcium,
(39).

and

10 ng/ml) was associated with increased ^H-thymidine
inositol

trisphosphate

diacylglycerol

production

release,
in

rat

increased
aortic

intracellullar

smooth

muscle

cells

In a second study examining the effects of PDGF isoforms on rat aortic

smooth muscle cells, Sachinidis, et al. found that PDGF-AB and PDGF-BB
were also
Na+/H+

associated with
exchanger,

an

increase in intracellular pH,

production

of smooth muscle cells (55).

of thromboxane

A2,

and

activation of the
caused

contraction

Westermark, et al. found that both membrane

ruffling and actin reorganization took place in the presence of PDGF-AB or
PDGF-BB (at 10 ng/ml to 100 ng/ml) and not in cells treated with PDGF-AA
(56).

These results are consistent with those found by Hammacher, et al. in

which human foreskin fibroblasts treated with PDGF-AB
demonstrated
not (30).
receptor

actin

reorganization

while

those treated

and PDGF-BB

with PDGF-AA

did

Based on the relationship between specific chains of PDGF and its
subunit binding

specificity

(Figure

1),

it

is

reasonable

to

that the proliferative response observed at five days in the present

presume
study

is

mediated by the interaction of PDGF-AB and PDGF-BB with the p receptor
subunit.

These isoforms will both bind to receptors containing a p

subunit

(PDGF-AB can bind to act or an aP receptors and PDGF-BB can bind to aa, ap,
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or (3p receptors).

Given that PDGF-AA is the only isoform which cannot

bind to a receptor containing a P

subunit and is the only isoform which did

not elicit a migratory or proliferative response after five days, it is
reasonable to infer that the p

subunit of the PDGF receptor is intimately

involved in these two actions.
valid

only

several

when

considering

This conclusion, however, appears to be
proliferation

or

possibly

migration

after

days.
Two studies have identified a proliferative effect of PDGF-AA.

Interestingly,

this

association

substantially

shorter

than

was

the

identified

initial

after

experiments

a

time

interval

in

this

study,

after 16 to 24 hours, by investigators using 3H-thymidine
their means

of assessing proliferation.

Sachinidis, et al.

namely

incorporation

as

found that there

was a variable degree of DNA synthesis in rat vascular smooth muscle cells
after 20 hours of PDGF-AA exposure but this required doses in excess of 10
ng/ml (52).

Majak, et al. found that recombinant PDGF-AA used at a greater

dose (50 ng/ml) was associated with significant 3H-thymidine
aortic smooth muscle cells (57).
at

uptake

in

rat

In that study, incorporation was measured

16 hours for sparsely grown cells and after 24 hours for confluent cells.

Two

of the

experiments

in

the present

investigation

which

demonstrated

proliferative response to PDGF-AA did so when 3H-thymidine

a

incorporation

was measured in BASMCs after 24 and 48 hours of PDGF-AA exposure (this
response was generated at
Specifically,

PDGF-AA

10 ng/ml in contrast to the studies cited).

generated

a highly

significant increase

in

DNA

synthesis at 24 hours, while PDGF-AB treatment was associated with a more
modest,

but

significant,

increase.

Given

the

receptor subunit

binding

specificities, it is likely that the early increase in 3H-thymidine
incorporation in the BASMCs treated with PDGF-AA (which can bind only to

;>
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a a receptors) and PDGF-AB (which can bind to a a or a P
represents

interaction

subunit.

of the

isoform

with

receptors

receptors)

containing

a

an

After 48 hours of treatment with the PDGF isoforms, however, the

BASMCs treated with each isoform had a significant increase in
thymidine
greatest

incorporation

increase

in

compared

to

incorporation

control,

over the

with

second

PDGF-BB

showing

the

24 hour period.

The observation that all of the isoforms of PDGF are associated with
increased
First,

^H-thymidine

several

incorporation

investigations

cited

used

raises

several

^H-thymidine

indirect measure of cell proliferation (50,57).
synthesis

(as

measured by

^H-thymidine

cell proliferation, an increase in
adequate

interesting

issues.

incorporation

as

an

While it is true that DNA

incorporation)

^H-thymidine

uptake

is

necessary

may

not

be

for

an

surrogate for cell number as a measure of proliferation.

Using

cell number as the gold standard for cell proliferation in BASMCs 24 and 48
hours

after

between
These

treatment

the

with

isoforms

findings

PDGF

identified

warrant

further

in

reflects

essentially

the

day

five

investigation

course of proliferation after PDGF treatment.

with

the

same

proliferation
regard

to

experiments.
the

time

The observation that PDGF-

AA treatment results in a dramatic increase in ^H-thymidine
while only

relationship

incorporation

inducing a modest increase in cell number, while the opposite is

true of PDGF-BB suggests that the a and P PDGF receptor subunits may be
linked to different

intracellular actions.

Dr.

Martin

Marx

has

demonstrated

that treatment of RFCs with PDGF results in phosphorylation of the
membrane

associated

proto-oncogene

c-src

within

of which isoform is used (data not shown) (58).
has

been

decreased

associated

with

cytoskeletal

Phosphorylation of c-src

reorganization

intercellular molecular transport

(56,60).

10 minutes regardless

in

epithelial

Bell, et

al.

cells

have

and

-D
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recently

demonstrated

increased migratory
the

that

BAECs

transfected

to

overexpress

rate compared to sham-transfected

phosphorylation

of c-src,

however,

the

specific

triggered by interaction of PDGF with the a and P

BAECs

c-src

have an

(61).

After

intracellular

subunit

remain

events
elusive.

While some investigations have suggested that the actions which PDGF has
on different cell types is a reflection of absolute and relative differences in
PDGF receptor expression (45,47), the observations generated by Dr.

Marx

and Bell, et al. illustrate what may be one of many intracellular steps
needed to

generate

the

behavioral

differences

seen

as

a result of treatment

with the PDGF isoforms.

The Effect of PDGF on_Speeific Vascular Cell Types
This study

sought to illustrate some of the differences between large

and small vessel endothelial cells by virtue of the way in which they react
to

treatment

with

PDGF.

Specifically,

treating microvascular capillary

endothelial cells, RFCs in this case, with PDGF elicited different responses
than treating large vessel endothelial cells, e.g., BAECs, with PDGF.
The differential effects that PDGF has on the two dimensional
proliferation of BAECs and RFCs illustrates that, while both are endothelial
cell
RFCs

cultures,
treated

these

cells

represent

very

with

PDGF

isoforms

demonstrated

while BAECs did not.
endothelial

cells

respond

of Bar, et al. (49).

different

populations.
increased

Specifically,

proliferation

This observation that capillary and arteriolar
differently

to PDGF is consistent

with

the

findings

In their study, bovine fat and mouse brain capillary

endothelial cells treated with PDGF showed increased ^H-thymidine
incorporation,
these events

a-amino

isobutyric

did not occur in

acid

bovine

and
aortic

2-deoxyglucose
and

pulmonary

uptake,
artery

while
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endothelial cells.

In addition, 125I-PDGF bound

to the

microvascular

endothelial cells but not the large vessel endothelial cells.
and Madri

Conversely, Bell

found that PDGF inhibited both proliferation and migration of

bovine aortic endothelial cells (17).

Both of these studies, however, were

conducted before the isolation of the individual PDGF isoforms and before
recombinant forms
between

the

of the

observation

isoforms
found

in

isolation of specific isoforms),

were generated.
investigations

Given the disparity

using

"PDGF"

with isoforms which were isolated, and now

with recombinant PDGF isoforms, it is likely that the early
preparations

were

earlier Findings,

contaminated

Bell

and

(before the

Madri

with

other

now

think

growth

PDGF

factors.

that the

Despite

inhibition

their

of migration

and proliferation of BAECs they noted may have reflected contamination of
the early PDGF preparations with TGF-0 (62).

While several studies have

evaluated the effects of nonrecombinant PDGF on endothelial

cells and the

effects of recombinant PDGF on vascular smooth muscle cells, it appears
that this

is the first investigation which compares the effects of the

recombinant PDGF isoforms in large and small vessel

endothelial

cells.

Interestingly, when BASMCs were treated with the PDGF isoforms,
these cells behaved similarly to the RFCs cultured in two dimensions.
Specifically, treatment with PDGF-BB and, to a lesser degree, PDGF-AB were
associated with

increased five day proliferation in both of these cell

These isoforms did not affect proliferation in BAECs.
illustrating the

similarities

between

these

two

Further evidence

populations

western blot performed by Ms. Adeline Tucker (Figure

types.

comes

14) (63).

from

a

This blot

demonstrates that RFCs and BASMCs grown on Type I collagen (i.e., in two
dimensions) express PDGF (3
the same manner did not.

receptor subunits whereas BAECs cultured in

While this finding does not preclude the

30

possibility of aa receptor expression on BAECs, antibodies to the a receptor
subunit were not commercially available at the time the blot was done.
However the lack of functional effects of PDGF in these cells make it
unlikely that these cells express any PDGF receptors.

The observation that

RFCs cultured in two dimensions on Type I collagen are phenotypically
similar to BASMCs and differ from large vessel endothelial cells is not a new
one.

In 1989, Kocher and Madri found that microvascular endothelial cells

(RFCs) grown on specific extracellular matrix components including Type I
collagen expressed a phenotype with features common to both endothelial
cells and smooth muscle cells (64).

Specifically, RFCs grown in two

dimensions stained positively for the expression of Factor VIII and
angiotensin-converting

enzyme

(both

markers

for

endothelial

differentiation and seen in BAECs) and also expressed a-smooth
specific actin, a marker for smooth muscle differentiation.

cell
muscle-

The list of

phenotypic similarities between BASMCs and RFCs now includes the
increase in proliferation associated with PDGF treatment and the common
expression of PDGF p receptor receptor subunits in cells cultured in two
dimensions.

These findings support the hypothesis put forth by Kocher

and Madri that RFCs and BASMCs may be closely related and may even be
the descendents of a common progenitor cell (64).
This hypothesis that BASMCs and RFCs have a common ancestor
could be further strengthened with the tools available currently by
examining

a-smooth

muscle-specific

with the different isoforms of PDGF.

actin

expression

after

stimulation

Several investigators have found that

smooth muscle cells which are actively proliferating do not express asmooth muscle-specific actin the way quiescent smooth muscle cells do.
Studies by Bjorkerud, and Blank and Owens found that smooth muscle cells

-D
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treated with PDGF had an increase in DNA synthesis (i.e., they were actively
proliferating)

and

actin (65,66).

a concomitant decrease

in

a-smooth

muscle-specific

Both of these studies support the Finding that PDGF promotes

smooth muscle cells to enter the cell cycle while decreasing expression of
a-smooth muscle-specific actin.

No study, however, has yet addressed the

idea that the different PDGF isoforms may result in differential effects on
a-smooth muscle-specific

actin expression.

Given the findings of the

present study, it would be expected that all the isoforms would induce these
changes, though at different points in time.
relationship between the PDGF isoforms

In addition, if the same

and a-smooth

muscle-specific

actin

held true in RFCs, it would strengthen the contention that BASMCs and RFCs
are

closely

related.

Modulation of Cell Phenotype in Two and Three Dimensional Cultures
The similarities between RFCs and BASMCs, however, only hold true
in two

dimensional

cultures.

There was no

increase in proliferation

found

when the effect of the PDGF isoforms on RFCs grown in three dimensional
Type I collagen gels was measured.

Conversely, BASMCs grown in three

dimensions and treated with PDGF continued to demonstrate the same
relationship
dimensions.

between

the

isoforms

in

cells

grown

in

two

Finally, BAECs grown in three dimensional culture failed to

respond to PDGF treatment,
dimensions.

identified

consistent with the

findings generated

in two

This disparity in RFC proliferation in two and three

dimensions is paralleled by the findings of Ms. Adeline Tucker who did not
identify PDGF (3

receptor subunits on RFCs grown in three dimensions while

present when RFCs were grown in two dimensions (Figure
Further

evidence

of

the

phenotypic

differences

generated

14) (63).
by

culturing

n)
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RFCs in two and three dimensions comes from Kocher and Madri (64).
These investigators found that RFCs cultured in a three dimensional Type I
collagen gel did not express a-smooth

muscle-specific

actin

as they

when cultured in two dimensions nor did they identify a-smooth
specific actin in RFCs grown in vivo.
morphology

in

two

and

three

had

muscle-

This disparity between RFC

dimensional

cultures

was

further

described

by Madri, et al. who reported that RFCs in three dimensions formed
multicellular

capillary-like

tubes

with

develop distinct cell polarity (51).

lumina,

form

tight junctions,

and

In contrast, RFCs cultured in two

dimensions fail to form tubes, tight junctions, or specialized of regions of
the

cell

membrane.

These

findings

raise

the

question

whether

assessing

RFC behavior based on two dimensional cultures is appropriate.
this, the

Despite

finding that RFCs are cells capable of modulating their phenotype

based on culture conditions while other types of endothelial cells

(e.g.,

BAECs)

the

cannot is not diminished

and raises questions

concerning

ancestry of RFCs as well as the pericyte.
This
the

ontologic

pericyte,

the

cell

question

is

pertinent

responsible

when

for providing

discussing

the

vascular tone

to

origin

of

capillaries

in the same fashion that smooth muscle cells provide tone for larger
vessels.

Because the pericyte expresses a-smooth

muscle-specific

actin,

some contend that these cells are the descendants of smooth muscle cells
which

have

pericytic

and

possibility

pericytes.
muscle

into

morphology.

(50,54,64)
the

migrated

capillary

The

supported

by

that capillary

walls

evidence
the

and

redifferentiated

to

by

coworkers

generated

findings of the

endothelial

Madri

present

cells may

be

the

and

their

investigation

raise

progenitor of

Given that RFCs are plastic cells in that they behave like smooth

cells

(including

expressing

markers

of

smooth

muscle

'D
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differentiation)

when

cultured

when cultured in three
candidate

as

in

two

dimensions

dimensions, this cell

and

like

population

endothelial

seems

cells

a likely

the progenitor of the pericyte.

Conclusion
The present study has demonstrated that the isoforms of PDGF have
differing effects on selected vascular cells.

Specifically, PDGF-AA is

associated with increased DNA synthesis in BASMCs (an indirect
measurement of cell proliferation) within the first 24 to 48
stimulation

and is diminished thereafter.

hours after

This effect is probably

through the a receptor subunit of the PDGF receptor.

mediated

Treatment with PDGF-

AB and PDGF-BB was associated with an increase in cell proliferation and
migration after several days.

This effect is likely regulated through the

p

subunit of the PDGF receptor.
This

investigation

also

presented

data

which

supported

the

argument that RFCs are a plastic cell population, capable of modulating its
morphology

based on external

conditions.

Specifically,

it was

demonstrated

that RFCs, when cultured in two dimensions, expressed PDGF p

receptor

subunits

similar to

and

BASMCs.

exhibited

two

dimensional

proliferation

which

is

Conversely, when cultured in a three dimensional Type I collagen

gel, RFCs lost their BASMC-like phenotype and behaved in a fashion similar
to BAECs, large vessel endothelial cells.
These findings point to several roles PDGF may play in clinical
circumstances,

including

having

a

beneficial

impact

on

wound

healing.

Greenhalgh, et al., in their study of skin wounds in diabetic mice found a
dramatic increase in both the rate in strength of wounds treated
(21).

with PDGF

In the first human trial of PDGF, Robson, et al. sprayed recombinant
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PDGF-BB

(100

pg/rnl) on chronic non-healing pressure sores (up to

165

months old) for one month and found 96% decrease pressure sore volume
compared to
revealed

an

healing

pretreatment
increased

wounds

(67).

number of fibroblasts

and

there

was

scarring or keloid formation.
generated
involved

increases
in

exogenous

wound

in

the

detrimental

no

long-term

is

migration
beneficial

endothelial

evidence

cells

wounds
in

the

of hypertrophic

and

proliferation

represent one

of the

possible

cells

use

for

growth factor.

in which migration

represent

and

of these

Clinical settings such as this in which PDGFcell

healing

forms of this

Settings

Histological examination

and

proliferation of these

another venue in PDGF research.

To

cells

is

some degree,

migration and proliferation of smooth muscle cells at the site of vascular
injury

is maladaptive in that it leads to neointima formation

perpetuates

the

considered

to

cycle
be

one

medicine

especially

coronary

angioplasty.

exposure

of the

cascade

which

of vascular injury.
of the

with

regard

In

basement

leads

to

main

this

Circumventing

challenges

to

the

use

setting,

membrane

facing

this process

circulating

stimualtion of smooth

of events,

it

is

understandable

remains a major problem
Recent

investigations

growth

factor-induced

have

why

transluminal

denudation

and

platelets

initiates

the

muscle cell proliferation,

migration, and neointima formation by factors such as PDGF.
chain

is

cardiovascular

of percutaneous

endothelial

to

and

restenosis

after

Given this
angioplasty

in the long term success of this procedure.
turned

smooth

toward

muscle

cell

the

possible

migration

regulation
and

of

proliferation.

Naftilan, et al. have identified a dramatic up-regulation of PDGF-A chain
mRNA expressed

in quiescent rat

with Angiotensin II (68).

aortic smooth muscle cells when treated

Araki, et al. demonstrated that Angiotensin II
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did

not induce

a mitogenic response in rabbit vascular smooth muscle

cells, but that the combination of Angiotensin II and PDGF was associated
with DNA synthesis to almost twice the degree induced by PDGF alone
(69).

Recent findings from Bell and Madri demonstrated both the

Angiotensin

Converting

Angiotensin

II

in bovine

Enzyme

antagonist,

aortic

Inhibitor,

Saralasin,

were

Lisinopril,
associated

endothelial cell migration (70).

and
with

the
41%

increase

Conversely, the

treatment of bovine aortic smooth muscle cells with these factors did not
significantly
with

affect migration.

Angiotensin

migration

while the

had no effect.
and

II

resulted
treatment

Treatment of the
in

a

highly

of the

smooth muscle

significant

endothelial

increase

cells

with

cells

in

this

factor

These observations have led to the belief that the PDGF

Angiotensin systems

are

intimately

linked

and

it seems

likely

that

the ability to regulate PDGF effects may come through manipulation of
the Angiotensin system.
major

implications

in

It is clear that this line of research will have
the

treatment

of atherosclerotic

disease.

"T)
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PDGF

Figure

1.

Platelet-Derived Growth

Factor Binding Specificity.
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PDGF-AA
PDGF-AB
PDGF-BB

PDGF Dose (ng/ml)

Figure 2.
Effects of the PDGF Isoforms at Differing Doses on the
Five Day Proliferation of RFCs Cultured in Two Dimensions.
*=Dose at which PDGF-BB differed from Control (1.25 ng/ml;
p-0.027).
**=Dose at which PDGF-AB differed from Control (2.5
ng/ml; p=0.010).
N=3 for each condition.

'■T>

% Change (in Cell Number)
From Control
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PDGF-AA
PDGF-AB
PDGF-BB

PDGF Dose (ng/ml)

Figure 3. Effects of the PDGF Isoforms at Differing Doses on the
Five Day Proliferation of BASMCs Cultured in Two Dimensions.
*=Dose at which PDGF-BB differed from Control (5.0 ng/ml;
p=0.024).
**=Dose at which PDGF-AB differed from Control (2.5
ng/ml; p=0.016).
N=4 for each condition.
Data courtesy of Dr.
Martin Marx.

T)

% Change (in Cell Number)
From Control
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PDGF Isoform

Figure 4. Effects of the PDGF Isoforms at 10 ng/ml on the Five Day
Proliferation of BAECs Cultured in Two Dimensions.
N=5 for each
condition.

D

% Change (in Cell Number)
From Control
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PDGF Isoform

Figure 5. Effects of the PDGF Isoforms at 10 ng/ml on the Five Day
Proliferation of RFCs Cultured in Two Dimensions.
N=4 for each
condition.

D

% Change (in Cell Number
From Control
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Figure 6. Effects of the PDGF Isoforms at 10 ng/ml on the Five Day
Proliferation of BASMCs Cultured in Two Dimensions.
N=4 for each
condition

42

48 Hour

PDGF Isoform

Figure 7. Effects of the PDGF Isoforms at 10 ng/ml on the 24 and
48 Hour Proliferation of BASMCs Cultured in Two Dimensions as
measured by Cell Counts.
N=4 for each condition.

D

43

V)

48 Hour

Figure 8. Effects of the PDGF Isoforms at 10 ng/ml on the 24 and 48
Hour ^H-Thymidine Incorporation of BASMCs Cultured in Two
Dimensions.
N=6 for each condition.
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PDGF Isoform

Figure 9. Effects of the PDGF Isoforms at 10 ng/ml on Five Day
Proliferation of BAECs in Three Dimensional Culture.
N=3 for
each condition.

*

% Change (in Ceil Number)
From Control
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Figure 10. Effects of the PDGF Isoforms at 10 ng/ml on Five
Day Proliferation of RFCs in Three Dimensional Culture.
N=3 for each condition.
Data courtesy of Dr. Martin Marx.

% Change (in Cell Number)
From Control
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PDGF-AA

PDGF-AB

PDGF-BB

PDGF Isoform

Figure 11. Effects of the PDGF Isoforms at 10 ng/ml on Five Day
Proliferation of BASMCs in Three Dimensional Culture.
N=2 for
each condition.

% Change (in Cell Area)
From Control
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30 n

20

-

iop = NS

P=NS

^

PDGF-AA

PDGF-AB

PDGF-BB

PDGF Isoform

Figure 12. Effects of the PDGF Isoforms at 10 ng/ml on Five Day
Radial Migration of BAECs.
N=10 for each condition.

% Change (in Cell Area)
From Control
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Figure 13. Effects of the PDGF Isoforms at 10 ng/ml on Five Day
Radial Migration of BASMCs.
N=5 for each condition.
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BAEC

I

2D-RFC

3D-RFC

BASMC

212kO
170kD
116kD
97kD -

76kD •

43kD -

Figure 14.
Western Blot Illustrating PDGF Receptor Expression in BAECs (in
two dimensions:
170kDa band absent), RFCs (in two dimensions:
approx.
170kDa bands present), RFCs (in three dimensions:
170kDa band absent), and
BASMCs (in two dimensions:
approx. 170kDa bands present).
Blot courtesy of
Ms. Adeline Tucker.
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